[
  {
    "ts": null,
    "headline": "Taking Stock of Elevance Health (ELV)’s Valuation After Digital Health Push and Board Refresh",
    "summary": "Elevance Health (ELV) just paired a broader rollout of its AI powered Virtual Assistant with the appointment of veteran healthcare deal maker and governance expert Amy Schulman to its board, a combination investors should parse carefully. See our latest analysis for Elevance Health. Those digital health moves and the Schulman appointment are landing against a clear shift in sentiment, with the share price up 14.3 percent over the past month but a three year total shareholder return still...",
    "url": "https://finnhub.io/api/news?id=ad9bd6889e35c61b8b266f1cf428a07a8ac4dd164be6b3fa8b85556331ef528a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765494743,
      "headline": "Taking Stock of Elevance Health (ELV)’s Valuation After Digital Health Push and Board Refresh",
      "id": 137767099,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health (ELV) just paired a broader rollout of its AI powered Virtual Assistant with the appointment of veteran healthcare deal maker and governance expert Amy Schulman to its board, a combination investors should parse carefully. See our latest analysis for Elevance Health. Those digital health moves and the Schulman appointment are landing against a clear shift in sentiment, with the share price up 14.3 percent over the past month but a three year total shareholder return still...",
      "url": "https://finnhub.io/api/news?id=ad9bd6889e35c61b8b266f1cf428a07a8ac4dd164be6b3fa8b85556331ef528a"
    }
  },
  {
    "ts": null,
    "headline": "How Investors May Respond To Elevance Health (ELV) Expanding AI Assistant Access And Adding Schulman To Board",
    "summary": "Elevance Health recently expanded access to its AI-powered Virtual Assistant for about 22 million commercial members and announced that Amy Schulman, a senior healthcare executive and governance expert, will join its board and sit on the Audit and Finance Committees in January 2026. Together, these moves highlight Elevance Health’s push to blend digital-first member support with strengthened board oversight in healthcare innovation and regulatory strategy. We’ll now examine how the broader...",
    "url": "https://finnhub.io/api/news?id=f6b3191f4932abd1d82f5154e4853a631dd39b9314866e553945987832a5ca45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765483736,
      "headline": "How Investors May Respond To Elevance Health (ELV) Expanding AI Assistant Access And Adding Schulman To Board",
      "id": 137762447,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health recently expanded access to its AI-powered Virtual Assistant for about 22 million commercial members and announced that Amy Schulman, a senior healthcare executive and governance expert, will join its board and sit on the Audit and Finance Committees in January 2026. Together, these moves highlight Elevance Health’s push to blend digital-first member support with strengthened board oversight in healthcare innovation and regulatory strategy. We’ll now examine how the broader...",
      "url": "https://finnhub.io/api/news?id=f6b3191f4932abd1d82f5154e4853a631dd39b9314866e553945987832a5ca45"
    }
  },
  {
    "ts": null,
    "headline": "Senate rejects Obamacare credit renewal, teeing up premium spike",
    "summary": "With only a few days left before lawmakers leave for their Christmas break and few signs of life in stalled bipartisan negotiations, the failure Thursday of the dueling partisan plans all but guarantees the expiration of enhanced Affordable Care Act tax credits initiated during the pandemic era.  Premium costs on average will more than double for people enrolled in Obamacare plans, forcing many of them to make hard choices on their health coverage and household finances.  The outcome will have wide-ranging consequences for insurance companies, a health-care sector that accounts for one-sixth of the US economy and potentially next year’s midterm elections.",
    "url": "https://finnhub.io/api/news?id=00c71fe5c93612ff95b0d72b65936cd5a1cbb4d1806ecb1301d941b62ff6c59c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765476486,
      "headline": "Senate rejects Obamacare credit renewal, teeing up premium spike",
      "id": 137760197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "With only a few days left before lawmakers leave for their Christmas break and few signs of life in stalled bipartisan negotiations, the failure Thursday of the dueling partisan plans all but guarantees the expiration of enhanced Affordable Care Act tax credits initiated during the pandemic era.  Premium costs on average will more than double for people enrolled in Obamacare plans, forcing many of them to make hard choices on their health coverage and household finances.  The outcome will have wide-ranging consequences for insurance companies, a health-care sector that accounts for one-sixth of the US economy and potentially next year’s midterm elections.",
      "url": "https://finnhub.io/api/news?id=00c71fe5c93612ff95b0d72b65936cd5a1cbb4d1806ecb1301d941b62ff6c59c"
    }
  },
  {
    "ts": null,
    "headline": "Ex-Pfizer executive joins Elevance’s board as insurer pursues pharmacy experience",
    "summary": "Amy Schulman is the second veteran of the pharmaceutical industry that Elevance has added to its board this year.",
    "url": "https://finnhub.io/api/news?id=6b3540eb8985d41f895cd697fed37777b0722c89fbe664732df4d79b3f597393",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765442751,
      "headline": "Ex-Pfizer executive joins Elevance’s board as insurer pursues pharmacy experience",
      "id": 137758844,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Amy Schulman is the second veteran of the pharmaceutical industry that Elevance has added to its board this year.",
      "url": "https://finnhub.io/api/news?id=6b3540eb8985d41f895cd697fed37777b0722c89fbe664732df4d79b3f597393"
    }
  },
  {
    "ts": null,
    "headline": "2 S&P 500 Stocks to Research Further and 1 We Question",
    "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
    "url": "https://finnhub.io/api/news?id=608049bd1de47fc899ccdd317020394c0c00cd4855637d29ffe55ac9da6c7f75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765427512,
      "headline": "2 S&P 500 Stocks to Research Further and 1 We Question",
      "id": 137762305,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
      "url": "https://finnhub.io/api/news?id=608049bd1de47fc899ccdd317020394c0c00cd4855637d29ffe55ac9da6c7f75"
    }
  }
]